9th Clinical Biomarkers & World CDx Boston 2018 summit

2 October - 5 October, 2018

info@world-cdx.com

+1 415 735 3289

http://world-cdx.com/

The Renaissance Boston Waterfront, USA

Event Type:

Organized By:

Hanson Wade

info@hansonwade.com

https://hansonwade.com/

About 9th Clinical Biomarkers & World CDx Boston 2018 summit

Enhance the Translation & Clinical Validation of Novel Predictive Biomarkers & Maximize the Commercialization of Diagnostic-Enabled Precision Medicines

The 9th Clinical Biomarkers & World CDx Boston 2018 summit is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD.

As the place to be for the precision medicine field, Clinical Biomarkers & World CDx Boston covers end-to-end the development, clinical implementation and commercialisation of a biomarker strategy to increase market penetration and market share for a targeted therapeutic. Ultimately, the meeting is here to streamline the path from R&D to providing patients with the right treatment decision and most effective therapies at the right time.

Speakers

Speaker

More...

Exhibitors Profile

Companion Diagnostics

Key topics to be addressed in 2018:

Building a commercial strategy to achieve a global footprint for precision medicine and its associated test
Overcoming hurdles in reimbursement for diagnostic enabled therapeutics to improve adoption and uptake in healthcare
Accelerating the demonstration of clinical utility and regulatory success for diagnostic-enabled precision medicines
Improving drug-IVD co-development to streamline the clinical development, approval and launch of a drug-Dx product

Clinical Biomarkers

Key topics to be addressed in 2018:

Advancing clinical validation of patient stratifying predictive biomarkers to robustly define selection approaches
Overcoming disparity in validation and standardization of assays to improve precision medicine development and adoption
Building the best biomarker driven precision medicine clinical trials to fast-track candidate efficacy demonstration and approval
Accelerating the translational development of predictive signatures to improve and streamline exploratory biomarker strategies

Event Partners

GEN

Pharmacogentics

Clinical Omnics

Diagnostics World

Technology Networks

More...

Post/Register Your Event

Quick Links

Media Pack Download

Newsletters

Event Location Map

The Renaissance Boston Waterfront, USA

Organizer Testimonials

<p>I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.</p>

Baoping Wang

Novo Nordisk (China) R&D Centre

<p>Working with Ochre has been one of the most rewarding experiences of my career. Their attention to detail, innovative approach, and unwavering commitment to excellence set them apart from others in the pharma industry. They are a professional media information platform recognized by the industry. I am confident that anyone who chooses to collaborate with them will be equally impressed. Thanks for making such a positive impact on CPHI & PMEC China.</p>